Methods of treating diseases with a VEGF antagonist
US7531172B2 · kind B2 · utility
28Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2006 |
| Grant date | May 12, 2009 |
| Priority date | — |
| Expiry date | Dec 13, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing or preventing hypertension associated with administration of a vascular endothelial growth factor (VEGF) antagonist in a human subjects suffering from a disease or condition treatable with a VEGF antagonist in which is it desirable to reduce or prevent hypertension. The method is particularly useful for treatment of patients unresponsive to treatment with a VEGF inhibitor administered intravenously.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.